Home / News / Now Pfizer and BioNTech Say Their COVID-19 Vaccine Candidate Is 95% Effective / Now-Pfizer-and-BioNTech-Say-Their-COVID-19-Vac
Recent Posts
- Join NJ ACTS Special Populations Core Seminar Series on 4/30 at 1pm
- NJACTS Community Engagement Core COVID-19 Resources
- Long-Acting Opioids May Be Unnecessary in Study of Total Knee Replacement.
- Predicting Loneliness Through Online Digital Footprints.
- $265K Awarded to NJIT Researchers Via New Jersey Health Foundation Grants.
Categories
- News (2,125)
- Publication (1)